Vasomotor Symptoms of Menopause (Hot Flashes) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Vasomotor Symptoms of Menopause (Hot Flashes) – Drugs In Development, 2024 report and make more profitable business decisions.
Vasomotor symptoms of menopause include hot flashes or night sweats that result from the sudden opening of blood vessels close to the skin, usually due to hormonal fluctuations in menopause and perimenopause. These symptoms can also be caused by some medications, estrogen withdrawal, thyroid disease, diabetes, hyperhidrosis, anxiety and panic disorders, obesity, hormonally active tumors, chronic infections, and neurological disorders.
The Vasomotor Symptoms of Menopause (Hot Flashes) drugs in development market research report provide comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Vasomotor Symptoms of Menopause (Hot Flashes) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 16 molecules, with 16 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Vasomotor Symptoms of Menopause (Hot Flashes) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Vasomotor Symptoms of Menopause (Hot Flashes) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Vasomotor Symptoms of Menopause (Hot Flashes) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Acrux LtdAstellas Pharma Inc
Bayer AG
Dare Bioscience Inc
Endoceutics Inc
Estrigenix Therapeutics Inc
Fervent Pharmaceuticals LLC
Iaterion Inc
Jiangsu Hansoh Pharmaceutical Group Co Ltd
MenoGeniX Inc
Mithra Pharmaceuticals SA
Mitsubishi Tanabe Pharma Corp
Que Oncology Inc
TherapeuticsMD Inc
VistaGen Therapeutics Inc
Zharko Pharma Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Vasomotor Symptoms of Menopause (Hot Flashes) reports